0
Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer. (pnas.org)
Authors:
Traphagen NA
… Brown M
Journal:
PNAS
Published:
2026-02-03
DOI:
https://doi.org/10.1073/pnas.2515790122
Comments
Login to comment.
No comments yet. Be the first!